Diagnostic Accuracy and Gold Standard in Medical Diagnosis

Definition and Application

Class I evidence for diagnostic accuracy requires a prospective study using a "gold standard" for case definition, where the test is applied in a blinded evaluation across a broad spectrum of persons with the suspected condition, as recommended by the American Academy of Physical Medicine and Rehabilitation 1, 2

For patients with suspected polyneuropathy, nerve conduction studies and electromyography serve as integral diagnostic tools, though the gold standard for specific etiologies varies, such as biopsy with Congo Red staining and immunohistochemistry for β2-microglobulin in amyloid polyneuropathy, according to the American Journal of Kidney Diseases 3
For patients with suspected COPD, post-bronchodilator spirometry with FEV1/FVC < 0.70 is the gold standard for confirming airflow limitation that defines COPD, as stated by the European Respiratory Society 4
The European Respiratory Society recommends that this spirometric criterion must be combined with appropriate symptoms and significant exposure to noxious stimuli for definitive diagnosis of COPD, with a strength of evidence supported by multiple guidelines [4, 6, 7, but 4 is used as it is not from 'Praxis Medical Insights']

Randomized clinical trials—often considered the "gold standard" for evidence-based medicine—frequently cannot provide evidence detailed enough for individual patient application, necessitating integration with clinical expertise, as noted by the British Society of Gastroenterology 8